PARATEK PHARMACEUTICALS INC's ticker is PRTK and the CUSIP is 699374302. A total of 111 filers reported holding PARATEK PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 0.59 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $41,769 | +6.1% | 18,900 | +21.9% | 0.00% | – |
| Q1 2023 | $39,370 | +35.8% | 15,500 | 0.0% | 0.00% | – |
| Q4 2022 | $28,985 | -77.2% | 15,500 | -68.7% | 0.00% | -100.0% |
| Q3 2022 | $127,000 | +32.3% | 49,500 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $96,000 | -34.7% | 49,500 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $147,000 | -33.2% | 49,500 | +1.0% | 0.00% | -50.0% |
| Q4 2021 | $220,000 | +33.3% | 49,000 | +44.1% | 0.00% | +100.0% |
| Q3 2021 | $165,000 | +79.3% | 34,000 | +161.5% | 0.00% | 0.0% |
| Q1 2021 | $92,000 | +13.6% | 13,000 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $81,000 | +5.2% | 13,000 | -8.5% | 0.00% | 0.0% |
| Q3 2020 | $77,000 | -70.0% | 14,200 | -71.1% | 0.00% | -66.7% |
| Q2 2020 | $257,000 | +46.9% | 49,200 | -11.7% | 0.00% | +50.0% |
| Q1 2020 | $175,000 | -21.9% | 55,700 | 0.0% | 0.00% | 0.0% |
| Q4 2019 | $224,000 | -7.1% | 55,700 | 0.0% | 0.00% | 0.0% |
| Q3 2019 | $241,000 | +8.6% | 55,700 | 0.0% | 0.00% | 0.0% |
| Q2 2019 | $222,000 | -28.6% | 55,700 | -4.0% | 0.00% | 0.0% |
| Q1 2019 | $311,000 | +2.6% | 58,000 | -1.7% | 0.00% | -33.3% |
| Q4 2018 | $303,000 | – | 59,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|